rs879576

Variant summary

Our verdict is Benign. The variant received -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BA1

The NM_014339.7(IL17RA):​c.1137G>A​(p.Lys379Lys) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.119 in 1,613,960 control chromosomes in the GnomAD database, including 12,799 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.15 ( 1892 hom., cov: 33)
Exomes 𝑓: 0.12 ( 10907 hom. )

Consequence

IL17RA
NM_014339.7 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: 1.31

Publications

24 publications found
Variant links:
Genes affected
IL17RA (HGNC:5985): (interleukin 17 receptor A) Interleukin 17A (IL17A) is a proinflammatory cytokine secreted by activated T-lymphocytes. It is a potent inducer of the maturation of CD34-positive hematopoietic precursors into neutrophils. The transmembrane protein encoded by this gene (interleukin 17A receptor; IL17RA) is a ubiquitous type I membrane glycoprotein that binds with low affinity to interleukin 17A. Interleukin 17A and its receptor play a pathogenic role in many inflammatory and autoimmune diseases such as rheumatoid arthritis. Like other cytokine receptors, this receptor likely has a multimeric structure. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Feb 2014]
IL17RA Gene-Disease associations (from GenCC):
  • immunodeficiency 51
    Inheritance: AR Classification: STRONG, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
  • chronic mucocutaneous candidiasis
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -19 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.42).
BP6
Variant 22-17108356-G-A is Benign according to our data. Variant chr22-17108356-G-A is described in ClinVar as Benign. ClinVar VariationId is 340592.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=1.31 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.225 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
IL17RANM_014339.7 linkc.1137G>A p.Lys379Lys synonymous_variant Exon 13 of 13 ENST00000319363.11 NP_055154.3 Q96F46-1
IL17RANM_001289905.2 linkc.1035G>A p.Lys345Lys synonymous_variant Exon 12 of 12 NP_001276834.1 Q96F46-2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
IL17RAENST00000319363.11 linkc.1137G>A p.Lys379Lys synonymous_variant Exon 13 of 13 1 NM_014339.7 ENSP00000320936.6 Q96F46-1
IL17RAENST00000612619.2 linkc.1035G>A p.Lys345Lys synonymous_variant Exon 12 of 12 5 ENSP00000479970.1 Q96F46-2

Frequencies

GnomAD3 genomes
AF:
0.146
AC:
22154
AN:
152056
Hom.:
1890
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.229
Gnomad AMI
AF:
0.0636
Gnomad AMR
AF:
0.121
Gnomad ASJ
AF:
0.228
Gnomad EAS
AF:
0.000193
Gnomad SAS
AF:
0.106
Gnomad FIN
AF:
0.113
Gnomad MID
AF:
0.190
Gnomad NFE
AF:
0.116
Gnomad OTH
AF:
0.151
GnomAD2 exomes
AF:
0.114
AC:
28544
AN:
251174
AF XY:
0.115
show subpopulations
Gnomad AFR exome
AF:
0.236
Gnomad AMR exome
AF:
0.0759
Gnomad ASJ exome
AF:
0.228
Gnomad EAS exome
AF:
0.000598
Gnomad FIN exome
AF:
0.111
Gnomad NFE exome
AF:
0.117
Gnomad OTH exome
AF:
0.120
GnomAD4 exome
AF:
0.116
AC:
169645
AN:
1461784
Hom.:
10907
Cov.:
54
AF XY:
0.117
AC XY:
84805
AN XY:
727198
show subpopulations
African (AFR)
AF:
0.232
AC:
7780
AN:
33480
American (AMR)
AF:
0.0798
AC:
3570
AN:
44720
Ashkenazi Jewish (ASJ)
AF:
0.228
AC:
5970
AN:
26132
East Asian (EAS)
AF:
0.000327
AC:
13
AN:
39700
South Asian (SAS)
AF:
0.111
AC:
9558
AN:
86258
European-Finnish (FIN)
AF:
0.113
AC:
6016
AN:
53378
Middle Eastern (MID)
AF:
0.233
AC:
1344
AN:
5762
European-Non Finnish (NFE)
AF:
0.115
AC:
127745
AN:
1111962
Other (OTH)
AF:
0.127
AC:
7649
AN:
60392
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.488
Heterozygous variant carriers
0
8894
17788
26682
35576
44470
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
4670
9340
14010
18680
23350
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.146
AC:
22171
AN:
152176
Hom.:
1892
Cov.:
33
AF XY:
0.144
AC XY:
10679
AN XY:
74394
show subpopulations
African (AFR)
AF:
0.229
AC:
9506
AN:
41492
American (AMR)
AF:
0.120
AC:
1842
AN:
15302
Ashkenazi Jewish (ASJ)
AF:
0.228
AC:
792
AN:
3472
East Asian (EAS)
AF:
0.000193
AC:
1
AN:
5170
South Asian (SAS)
AF:
0.106
AC:
512
AN:
4824
European-Finnish (FIN)
AF:
0.113
AC:
1200
AN:
10598
Middle Eastern (MID)
AF:
0.187
AC:
55
AN:
294
European-Non Finnish (NFE)
AF:
0.116
AC:
7887
AN:
67998
Other (OTH)
AF:
0.150
AC:
318
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
980
1960
2940
3920
4900
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
234
468
702
936
1170
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.121
Hom.:
1852
Bravo
AF:
0.150
Asia WGS
AF:
0.0580
AC:
202
AN:
3478
EpiCase
AF:
0.129
EpiControl
AF:
0.126

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:1
Jan 24, 2024
Unidad de Genómica Garrahan, Hospital de Pediatría Garrahan
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is classified as Benign based on local population frequency. This variant was detected in 26% of patients studied by a panel of primary immunodeficiencies. Number of patients: 25. Only high quality variants are reported. -

Familial Candidiasis, Recessive Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Immunodeficiency 51 Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.42
CADD
Benign
6.9
DANN
Benign
0.60
PhyloP100
1.3
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs879576; hg19: chr22-17589246; API